Biocartis Group Past Earnings Performance
Past criteria checks 0/6
Biocartis Group's earnings have been declining at an average annual rate of -10.5%, while the Medical Equipment industry saw earnings declining at 9.5% annually. Revenues have been growing at an average rate of 23.3% per year.
Key information
-10.5%
Earnings growth rate
-5.8%
EPS growth rate
| Medical Equipment Industry Growth | -9.5% |
| Revenue growth rate | 23.3% |
| Return on equity | n/a |
| Net Margin | -107.4% |
| Next Earnings Update | 10 Nov 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Biocartis Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 59 | -63 | 35 | 0 |
| 31 Mar 22 | 57 | -67 | 34 | 0 |
| 31 Dec 21 | 55 | -71 | 32 | 0 |
| 30 Sep 21 | 58 | -70 | 32 | 0 |
| 30 Jun 21 | 61 | -69 | 32 | 0 |
| 31 Mar 21 | 58 | -66 | 31 | 0 |
| 31 Dec 20 | 56 | -63 | 30 | 0 |
| 30 Sep 20 | 47 | -64 | 31 | 0 |
| 30 Jun 20 | 38 | -66 | 31 | 0 |
| 31 Mar 20 | 38 | -65 | 32 | 0 |
| 31 Dec 19 | 38 | -64 | 32 | 0 |
| 30 Sep 19 | 35 | -60 | 30 | 0 |
| 30 Jun 19 | 33 | -56 | 28 | 0 |
| 31 Mar 19 | 31 | -52 | 25 | 0 |
| 31 Dec 18 | 29 | -48 | 23 | 0 |
| 30 Sep 18 | 29 | -44 | 22 | 0 |
| 30 Jun 18 | 29 | -40 | 21 | 0 |
| 31 Mar 18 | 26 | -41 | 20 | 0 |
| 31 Dec 17 | 23 | -42 | 18 | 0 |
| 30 Sep 17 | 19 | -46 | 17 | 0 |
| 30 Jun 17 | 14 | -50 | 16 | 0 |
| 31 Mar 17 | 14 | -50 | 16 | 0 |
| 31 Dec 16 | 14 | -50 | 16 | 0 |
| 30 Sep 16 | 14 | -48 | 16 | 0 |
| 30 Jun 16 | 14 | -47 | 17 | 0 |
| 31 Mar 16 | 15 | -43 | 16 | 0 |
| 31 Dec 15 | 15 | -40 | 15 | 0 |
Quality Earnings: BCARTB is currently unprofitable.
Growing Profit Margin: BCARTB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BCARTB is unprofitable, and losses have increased over the past 5 years at a rate of 10.5% per year.
Accelerating Growth: Unable to compare BCARTB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BCARTB is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-12.2%).
Return on Equity
High ROE: BCARTB's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.